UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007595
Receipt number R000008967
Scientific Title Randomized control clinical trial to evaluate protective effects of combination therapy of ARB and DDP-4 inhibitor on pancreatic beta cell function
Date of disclosure of the study information 2012/05/01
Last modified on 2016/03/29 12:40:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized control clinical trial to evaluate protective effects of combination therapy of ARB and DDP-4 inhibitor on pancreatic beta cell function

Acronym

Protective effects of combination therapy of ARB and DDP-4 inhibitor on pancreatic beta cell function

Scientific Title

Randomized control clinical trial to evaluate protective effects of combination therapy of ARB and DDP-4 inhibitor on pancreatic beta cell function

Scientific Title:Acronym

Protective effects of combination therapy of ARB and DDP-4 inhibitor on pancreatic beta cell function

Region

Japan


Condition

Condition

Type 2 diabetes mellitus complicated with essential hypertension

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate whether combination therapy of ARB and DPP-4 inhibitor is more protective than that of ARB and sulfonylurea in terms of pancreatic beta cell function

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

ratio of pro-insulin to insulin, HOMA-beta

Key secondary outcomes

HbA1c, insulin sensitivity(HOMA-IR), body weight, blood pressure


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

new administration of DPP-4 inhibitor

Interventions/Control_2

new administration or loading of sulfonylurea

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Eligible outpatients met the following criteria:
1) Hypertensive patients with type 2 diabetes who are treated with ARB.
2) Type 2 diabetic patients taking oral hypoglycemic agents (sulfonylurea) or none with hemoglobin A1c level (JDS) more than 6.1% for at least 2 months.

Key exclusion criteria

Patients are excluded from the study if there is any evidence of type 1 diabetes, treatment with insulin, GLP-1 analog, and other hypoglycemic agent except for sulfonylurea, renal failure (serum creatinine: more than 1.5 mg/dl for male, 1.3 mg/dl for female), severe liver dysfunction, pregnancy and past history of diabetic coma within 6 months.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yamada Hiroyuki

Organization

Kyoto Prefectural University School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code


Address

465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566 Japan

TEL

075-251-5511

Email

hiyamada@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yamada Hiroyuki

Organization

Kyoto Prefectural University School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code


Address

465 Kjii-cho Kamigyo-ku Kyoto City Japon

TEL

075-251-5511

Homepage URL


Email

hiyamada@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University School of Medicine Department of Cardiovascular Medicine

Institute

Department

Personal name



Funding Source

Organization

The Waksman Foundation of Japan INC

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Members of Kyoto Lifestyle Study Group: Hajime Shirai (Aiseikai
Yamashina Hospital); Yusuke Nakagawa, Kenzo Sakamoto,
Masaki Tsukamoto (Akashi City Hospital); Sinsaku Matsunaga
(Kyoto City Hospital); Satoshi Gojo, Naohiko Nakanishi (Kyoto
Prefectural University of Medicine); Yoshihiro Matsui, Hirokazu
Yokoi (Japanese Red Cross Kyoto Daiichi Hospital); Sumio
Komatsu (Komatsu Heart Clinic); Morihiko Kondo, ToshiyukiOtomo, Tetsuya Tanaka, Kazuto Yamamoto (Kobe Central
Hospital); Yoshifumi Nakahara (Saiseikai Shigaken Hospital);
Takeshi Takenaka (Takenaka Clinic); Shigeki Kusuoka, Keizo
Furukawa (Tanabe Central Hospital).


Other administrative information

Date of disclosure of the study information

2012 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1177%2F1470320315587180

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 01 Month 16 Day

Date of IRB


Anticipated trial start date

2012 Year 05 Month 01 Day

Last follow-up date

2013 Year 06 Month 01 Day

Date of closure to data entry

2013 Year 07 Month 01 Day

Date trial data considered complete

2013 Year 08 Month 01 Day

Date analysis concluded

2013 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2012 Year 03 Month 28 Day

Last modified on

2016 Year 03 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008967


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name